National Bank of Canada FI lifted its holdings in shares of AMETEK, Inc. (NYSE:AME – Get Rating) by 19.9% during the 3rd quarter, Holdings Channel.com reports. The firm owned 44,172 shares of the technology company's stock after acquiring an additional 7,343 shares during the period. National Bank of Canada FI's holdings in AMETEK were worth $5,180,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in AME. Skandinaviska Enskilda Banken AB publ increased its stake in shares of AMETEK by 124.5% during the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 16,092 shares of the technology company's stock valued at $2,143,000 after acquiring an additional 8,924 shares during the last quarter. Raymond James & Associates raised its stake in AMETEK by 1.2% during the first quarter. Raymond James & Associates now owns 166,585 shares of the technology company's stock worth $22,186,000 after purchasing an additional 1,903 shares during the period. Raymond James Financial Services Advisors Inc. grew its stake in shares of AMETEK by 0.4% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 89,058 shares of the technology company's stock valued at $11,862,000 after buying an additional 339 shares during the period. Veritable L.P. increased its holdings in shares of AMETEK by 2.9% during the 1st quarter. Veritable L.P. now owns 12,533 shares of the technology company's stock worth $1,669,000 after buying an additional 353 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. raised its position in shares of AMETEK by 9.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 4,306 shares of the technology company's stock worth $573,000 after buying an additional 376 shares during the period. Hedge funds and other institutional investors own 85.42% of the company's stock.

Analyst Upgrades and Downgrades

AME has been the subject of several research analyst reports. StockNews.com upgraded AMETEK from a "hold" rating to a "buy" rating in a research note on Tuesday, November 15th. Mizuho raised their price target on shares of AMETEK from $140.00 to $145.00 and gave the company a "buy" rating in a report on Wednesday, November 2nd. Morgan Stanley boosted their price objective on shares of AMETEK from $137.00 to $144.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 2nd. Royal Bank of Canada raised their target price on shares of AMETEK from $135.00 to $136.00 and gave the company an "outperform" rating in a research note on Wednesday, November 2nd. Finally, KeyCorp upped their price target on shares of AMETEK from $145.00 to $165.00 and gave the stock an "overweight" rating in a research report on Monday, November 21st. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $148.00.

AMETEK Stock Performance

AMETEK (NYSE:AME – Get Rating) last released its quarterly earnings results on Tuesday, November 1st. The technology company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.37 by $0.08. AMETEK had a return on equity of 18.40% and a net margin of 18.81%. The business had revenue of $1.55 billion for the quarter, compared to analysts' expectations of $1.51 billion. During the same quarter in the previous year, the firm posted $1.26 earnings per share. The company's revenue was up 7.7% compared to the same quarter last year. On average, research analysts anticipate that AMETEK, Inc. will post 5.63 earnings per share for the current fiscal year.

AMETEK Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 23rd. Shareholders of record on Wednesday, December 7th were paid a dividend of $0.22 per share. The ex-dividend date of this dividend was Tuesday, December 6th. This represents a $0.88 dividend on an annualized basis and a yield of 0.63%. AMETEK's dividend payout ratio (DPR) is 18.00%.

Insiders Place Their Bets

In related news, insider Thomas C. Marecic sold 10,000 shares of the business's stock in a transaction dated Wednesday, November 23rd. The stock was sold at an average price of $142.05, for a total value of $1,420,500.00. Following the completion of the sale, the insider now directly owns 31,622 shares of the company's stock, valued at $4,491,905.10. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other AMETEK news, insider Thomas C. Marecic sold 2,318 shares of the firm's stock in a transaction dated Monday, November 21st. The shares were sold at an average price of $141.01, for a total value of $326,861.18. Following the transaction, the insider now owns 31,622 shares of the company's stock, valued at $4,459,018.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Thomas C. Marecic sold 10,000 shares of the stock in a transaction that occurred on Wednesday, November 23rd. The stock was sold at an average price of $142.05, for a total value of $1,420,500.00. Following the sale, the insider now owns 31,622 shares in the company, valued at $4,491,905.10. The disclosure for this sale can be found here. 0.72% of the stock is owned by company insiders.

AMETEK Profile

(Get Rating)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Further Reading

• Get a free copy of the StockNews.com research report on AMETEK (AME)
• MarketBeat: Week in Review 12/19 – 12/23
• These Steelmakers Deserve A Place On Your 2023 Watch List
• Inflation Cools, Where Does The S&P 500 Go Now
• Cintas Beats Inflation With Operating Leverage
• Your Decision to Buy Palantir May Simply Be a Matter of Time

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Get Rating).

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.